Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lerman

Showing results (21-30 of 161) with videos related to

Pageof 17
Sort By:
Developments in Ophthalmology|January 1, 1991
Evaluation of risk factors in human cataractogenesisS Lerman
Lens and Eye Toxicity Research|January 1, 1989
Test models to determine potential ocular drug induced side effectsS Lerman
Israel Journal of Medical Sciences|August 1, 1972
Lens proteins and fluorescenceS Lerman
JAMA|January 14, 1974
Letter: Take as directed?S Lerman
Developments in Ophthalmology|January 1, 1987
In vivo and in vitro investigations on cataract risk factorsS Lerman
Ophthalmology|March 1, 1986
Photosensitizing drugs and their possible role in enhancing ocular toxicity. Parker Heath memorial lectureS Lerman
The New England Journal of Medicine|December 1, 1988
Ocular phototoxicityS Lerman
The New England Journal of Medicine|October 16, 1980
Ocular side effects of psoriasis therapyS Lerman
Developments in Ophthalmology|January 1, 1989
In vivo lens fluorescence as a cataract markerS Lerman
National Cancer Institute Monograph|December 1, 1984
Psoralens and ocular effects in man and animals: in vivo monitoring of human ocular and cutaneous manifestationsS Lerman
Pageof 17

Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
Developments in Ophthalmology|January 1, 1991
Evaluation of risk factors in human cataractogenesisS Lerman
Lens and Eye Toxicity Research|January 1, 1989
Test models to determine potential ocular drug induced side effectsS Lerman
Israel Journal of Medical Sciences|August 1, 1972
Lens proteins and fluorescenceS Lerman
JAMA|January 14, 1974
Letter: Take as directed?S Lerman
Developments in Ophthalmology|January 1, 1987
In vivo and in vitro investigations on cataract risk factorsS Lerman
Ophthalmology|March 1, 1986
Photosensitizing drugs and their possible role in enhancing ocular toxicity. Parker Heath memorial lectureS Lerman
The New England Journal of Medicine|December 1, 1988
Ocular phototoxicityS Lerman
The New England Journal of Medicine|October 16, 1980
Ocular side effects of psoriasis therapyS Lerman
Developments in Ophthalmology|January 1, 1989
In vivo lens fluorescence as a cataract markerS Lerman
National Cancer Institute Monograph|December 1, 1984
Psoralens and ocular effects in man and animals: in vivo monitoring of human ocular and cutaneous manifestationsS Lerman
Pageof 17